These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8805872)

  • 1. HIV-1 p24 Gag-specific cytotoxic T-lymphocyte responses in mice.
    Doe B; Walker CM
    AIDS; 1996 Jun; 10(7):793-4. PubMed ID: 8805872
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24.
    Nishino Y; Kameoka M; Okada Y; Zhong Q; Kimura T; Azuma I; Ikuta K
    Vaccine; 1994 May; 12(6):485-91. PubMed ID: 7913566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.
    van Baalen CA; Klein MR; Huisman RC; Dings ME; Kerkhof Garde SR; Geretti AM; Gruters R; van Els CA; Miedema F; Osterhaus AD
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1659-65. PubMed ID: 8760412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
    Phillips RE; Rowland-Jones S; Nixon DF; Gotch FM; Edwards JP; Ogunlesi AO; Elvin JG; Rothbard JA; Bangham CR; Rizza CR
    Nature; 1991 Dec; 354(6353):453-9. PubMed ID: 1721107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
    Koup RA; Pikora CA; Luzuriaga K; Brettler DB; Day ES; Mazzara GP; Sullivan JL
    J Exp Med; 1991 Dec; 174(6):1593-600. PubMed ID: 1744586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other.
    Goulder PJ; Tang Y; Pelton SI; Walker BD
    J Virol; 2000 Jun; 74(11):5291-9. PubMed ID: 10799606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population.
    Kaushik S; Vajpayee M; Wig N; Seth P
    Clin Exp Immunol; 2005 Nov; 142(2):388-97. PubMed ID: 16232229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1.
    Pajot A; Schnuriger A; Moris A; Rodallec A; Ojcius DM; Autran B; Lemonnier FA; Lone YC
    Eur J Immunol; 2007 Sep; 37(9):2635-44. PubMed ID: 17668896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the generation and maintenance of mucosal cytotoxic T lymphocytes against human immunodeficiency virus type 1 Gag in mice.
    Yoshizawa I; Mizuochi T; Ogata A; Murakami M; Yagita H; Takahashi Y; Mizuochi T; Takemori T; Tsunetsugu-Yokota Y
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):469-79. PubMed ID: 12882656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
    Gudmundsdotter L; Bernasconi D; Hejdeman B; Sandstrom E; Alaeus A; Lidman K; Ensoli B; Wahren B; Buttò S
    Vaccine; 2008 Sep; 26(40):5182-7. PubMed ID: 18479789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an HIV-1 p24gag epitope recognized by a CD8+ cytotoxic T-cell clone.
    Buseyne F; Stevanovic S; Rammensee HG; Rivière Y
    Immunol Lett; 1997 Mar; 55(3):145-9. PubMed ID: 9161880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
    Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
    J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the level of blood suppressor CD8+CD57+ lymphocytes, when HIV-1 p24 antigen reappears in the blood.
    Mathé G; Morette C; Hallard M; Sala M; Orbach-Arbouys S
    Biomed Pharmacother; 1994; 48(1):3-5. PubMed ID: 7522602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability and immunogenicity of human immunodeficiency virus type 1 p24 gene quasispecies.
    Iroegbu J; Birk M; Lazdina U; Sönnerborg A; Sällberg M
    Clin Diagn Lab Immunol; 2000 May; 7(3):377-83. PubMed ID: 10799449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
    AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary proliferative responses to peptides of HIV Gag p24.
    Bedford PA; Clarke LB; Hastings GZ; Knight SC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Apr; 14(4):301-6. PubMed ID: 9111471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.